$9.69 1.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 10 0%
App downloads 0% N/A
Sentiment 89 0%
Webpage traffic 74,000 13.1%
Employee Rating 69 0%
Google Adspend $643 39.5% N/A
Google Trends 22 0%
Linkedin Employees 261 N/A
Patents 0%
4chan Mentions 0%
Facebook Engagement 10 11.1%
Facebook followers 7,265 -0%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 3,781 -0.1%
Twitter Followers 627 0%
Instagram Followers 46,033 0%
News Mentions 0%
Reddit Mentions -100%
Business outlook 56 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Evolus

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States.

Price $9.69
Target Price Sign up
Market Cap $544M
Dividend Yield 0
Industry Drug Manufacturers

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2346M60M-14M-17M-12M
Q2 '2346M57M-11M-18M-14M
Q1 '2339M50M-12M-15M-11M
Q4 '2241M51M-10M-13M-9.6M
Q3 '2232M49M-18M-20M-17M

Insider Transactions

Medytox Inc. filed to sell 3,381,326 shares at $7.5.
October 18 '23
Beaver Sandra filed to sell 113,368 shares at $9.7.
September 8 '23
MOATAZEDI DAVID filed to sell 686,592 shares at $10.3.
August 16 '23
Beaver Sandra filed to sell 116,546 shares at $10.3.
August 16 '23
Avelar Rui filed to sell 353,386 shares at $10.3.
August 16 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.